{"id":"https://openalex.org/W3132700063","doi":"https://doi.org/10.1177/1756286420987031","title":"Health economics of disease-modifying therapy for multiple sclerosis in the United States","display_name":"Health economics of disease-modifying therapy for multiple sclerosis in the United States","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3132700063","doi":"https://doi.org/10.1177/1756286420987031","mag":"3132700063","pmid":"https://pubmed.ncbi.nlm.nih.gov/33643441","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7894590"},"language":"en","primary_location":{"id":"doi:10.1177/1756286420987031","doi":"https://doi.org/10.1177/1756286420987031","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1756286420987031","pdf_url":null,"source":{"id":"https://openalex.org/S7261370","display_name":"Therapeutic Advances in Neurological Disorders","issn_l":"1756-2856","issn":["1756-2856","1756-2864"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Neurological Disorders","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1177/1756286420987031","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086002607","display_name":"Daniel M. Hartung","orcid":"https://orcid.org/0000-0002-0685-773X","observed_orcids":["https://orcid.org/0000-0002-0685-773X"]},"institutions":[{"id":"https://openalex.org/I131249849","display_name":"Oregon State University","ror":"https://ror.org/00ysfqy60","country_code":"US","type":"education","lineage":["https://openalex.org/I131249849"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel M. Hartung","raw_affiliation_strings":["College of Pharmacy, Oregon State University, 2730 SW Moody Ave CL5CP, Portland, OR 97201-5042, USA"],"raw_orcid":"https://orcid.org/0000-0002-0685-773X","affiliations":[{"raw_affiliation_string":"College of Pharmacy, Oregon State University, 2730 SW Moody Ave CL5CP, Portland, OR 97201-5042, USA","institution_ids":["https://openalex.org/I131249849"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5086002607"],"corresponding_institution_ids":["https://openalex.org/I131249849"],"apc_list":{"value":2400,"currency":"USD","value_usd":2400},"apc_paid":{"value":2400,"currency":"USD","value_usd":2400},"fwci":1.5771,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.83602151,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"14","issue":null,"first_page":"1756286420987031","last_page":"1756286420987031"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.8223000168800354,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.8223000168800354,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.14710000157356262,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.017500000074505806,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":1.0},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.8730000257492065},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.6869999766349792},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.6639999747276306},{"id":"https://openalex.org/keywords/out-of-pocket-costs","display_name":"out-of-pocket costs","score":0.9449999928474426},{"id":"https://openalex.org/keywords/relative-value","display_name":"relative value","score":0.6629999876022339},{"id":"https://openalex.org/keywords/patient-affordability","display_name":"patient affordability","score":0.36000001430511475},{"id":"https://openalex.org/keywords/united-states","display_name":"United States","score":0.6039999723434448}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7686483860015869},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6139786243438721},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.5315850377082825},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4971778690814972},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.4394252598285675},{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.4316655993461609},{"id":"https://openalex.org/C188897","wikidata":"https://www.wikidata.org/wiki/Q5333508","display_name":"Economic impact analysis","level":2,"score":0.4137982130050659},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.21277880668640137},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.1831997036933899},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.15070205926895142},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.14442557096481323},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.11972770094871521},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.0},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1177/1756286420987031","doi":"https://doi.org/10.1177/1756286420987031","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1756286420987031","pdf_url":null,"source":{"id":"https://openalex.org/S7261370","display_name":"Therapeutic Advances in Neurological Disorders","issn_l":"1756-2856","issn":["1756-2856","1756-2864"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Neurological Disorders","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7894590","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7894590","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Neurol Disord","raw_type":"Text"},{"id":"pmid:33643441","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33643441","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in neurological disorders","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:d087b5f5b12e4b129e129f1145e9ee12","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d087b5f5b12e4b129e129f1145e9ee12","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapeutic Advances in Neurological Disorders, Vol 14 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1177/1756286420987031","doi":"https://doi.org/10.1177/1756286420987031","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1756286420987031","pdf_url":null,"source":{"id":"https://openalex.org/S7261370","display_name":"Therapeutic Advances in Neurological Disorders","issn_l":"1756-2856","issn":["1756-2856","1756-2864"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Neurological Disorders","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306161","display_name":"National Multiple Sclerosis Society","ror":"https://ror.org/03019wv17"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W33609267","https://openalex.org/W56077096","https://openalex.org/W115991066","https://openalex.org/W172925500","https://openalex.org/W1963489266","https://openalex.org/W1976815310","https://openalex.org/W2038982872","https://openalex.org/W2040263764","https://openalex.org/W2058056848","https://openalex.org/W2061166054","https://openalex.org/W2067673653","https://openalex.org/W2088546205","https://openalex.org/W2107872222","https://openalex.org/W2123156857","https://openalex.org/W2127809083","https://openalex.org/W2131191887","https://openalex.org/W2131902490","https://openalex.org/W2133755641","https://openalex.org/W2140959461","https://openalex.org/W2151516700","https://openalex.org/W2173972826","https://openalex.org/W2185407368","https://openalex.org/W2281097070","https://openalex.org/W2417887036","https://openalex.org/W2469745209","https://openalex.org/W2509821732","https://openalex.org/W2512060983","https://openalex.org/W2527555398","https://openalex.org/W2536652674","https://openalex.org/W2608396028","https://openalex.org/W2736874896","https://openalex.org/W2737462209","https://openalex.org/W2754967293","https://openalex.org/W2761114208","https://openalex.org/W2783953512","https://openalex.org/W2787204655","https://openalex.org/W2799345901","https://openalex.org/W2807284925","https://openalex.org/W2908259812","https://openalex.org/W2914096077","https://openalex.org/W2914141021","https://openalex.org/W2942809567","https://openalex.org/W2969811032","https://openalex.org/W2986234717","https://openalex.org/W3009985280","https://openalex.org/W4250145052","https://openalex.org/W4319308236"],"related_works":["https://openalex.org/W3202496640","https://openalex.org/W7154404545","https://openalex.org/W3158062366","https://openalex.org/W2748489847","https://openalex.org/W1893735325","https://openalex.org/W2095712666","https://openalex.org/W2914096077","https://openalex.org/W7100332076","https://openalex.org/W2319419725","https://openalex.org/W2811325561"],"abstract_inverted_index":{"Multiple":[0],"sclerosis":[1],"(MS)":[2],"is":[3,16,61,97],"chronic":[4],"neuroinflammatory":[5],"condition":[6],"associated":[7],"with":[8],"significant":[9],"disability.":[10],"The":[11,91],"economic":[12,59,100],"burden":[13,70],"of":[14,31,36,93],"MS":[15,51,104],"substantial,":[17],"and":[18,20,57,85,112],"high":[19,75],"rising":[21],"disease-modifying":[22],"therapy":[23],"(DMT)":[24],"prices":[25],"are":[26],"the":[27,37,72,118],"single":[28],"largest":[29],"drivers":[30],"healthcare":[32,73],"expenditures.":[33],"Over":[34],"much":[35],"last":[38],"decade,":[39],"price":[40],"increases":[41],"for":[42,71],"most":[43],"DMTs":[44,52],"have":[45],"surpassed":[46],"10%":[47],"annually.":[48],"Currently,":[49],"many":[50],"exceed":[53],"US$90,000":[54],"a":[55,68],"year":[56],"their":[58],"value":[60],"widely":[62],"debated.":[63],"In":[64],"addition":[65],"to":[66,98,103],"creating":[67],"financial":[69],"system,":[74],"DMT":[76],"costs":[77,84],"negatively":[78],"impact":[79],"patients":[80],"through":[81],"unaffordable":[82],"out-of-pocket":[83],"excessive":[86],"restrictions":[87],"by":[88],"insurance":[89],"companies.":[90],"objective":[92],"this":[94],"narrative":[95],"review":[96],"summarize":[99],"issues":[101],"related":[102],"DMTs,":[105],"including":[106],"trends":[107],"in":[108,117],"pricing,":[109],"relative":[110],"value,":[111],"effects":[113],"on":[114],"patient":[115],"care":[116],"United":[119],"States.":[120]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":3}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2021-03-01T00:00:00"}